Prognostic significance of serum interleukin-6 in severe/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis.

Sci Rep · 2024 · PMC11605089 · PMID 39609511

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significanceP =0.140not close (p > 0.1)

While non-survivors exhibited higher baseline IL-6 levels than survivors, the observed difference did not reach statistical significance ( P =0.140).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.